Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People
July 21, 2014
TheStreet / Powered by NewsLook.com
New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York.
Video provided by TheStreet
AFP (Apr. 8, 2013) South Africa's health minister launches a new single dose anti-AIDS drug, which reduces the need for HIV positive patients to take multiple pills each day. The country has the largest HIV positive ... watch video
NDTV (May 7, 2013) It is not a girl's world, at least not in India where there are only 919 girls under six for every 1000 boys. The 2011 census figures show the ratio has fallen further from the already alarming 927 ... watch video
Newsy (July 10, 2014) The anonymous infant's "functional cure" last year raised hopes of a treatment for HIV-positive babies, but the virus finally re-emerged in the girl.
Video provided by ... watch video
FORA.tv (May 9, 2013) Dr Joep Lange has been involved in HIV research and treatment since 1983. He has been the architect and principal investigator of several pivotal trials on antiretroviral therapy and on the ... watch video
Newsy (July 22, 2015) Eli Lilly is debuting solanezumab, its new drug designed to cure Alzheimer's. But will the drug fare better than past trials have foreshadowed?
Video provided by ... watch video
Aug. 28, 2015 If you think that performing CPR on a person whose heart has stopped is a surefire way to save their life, you may be watching too much TV. The truth is more depressing than fiction, according to a ... read more
Aug. 28, 2015 Tumors are notoriously difficult to study in their natural habitat -- body tissues -- but a new synthetic tissue environment may give cancer researchers the next-best look at tumor growth and ... read more
Aug. 28, 2015 New research examines the experiences of California residents who have been prescribed medical marijuana and the stigma they experience from public opinion. The findings indicate that the stigma of ... read more
Aug. 28, 2015 A new international study shows that 5,000 fetuses in Europe annually are affected by spina bifida and other severe defects on the central nervous system. Seventy percent of these pregnancies are ... read more
Aug. 28, 2015 Researchers have unraveled a role for tumor suppressor genes in restricting the growth of neighboring cell populations. The study might have implications for understanding ... read more
Mar. 31, 2015 HIV (human immunodeficiency virus)-positive kidney transplant patients experienced superior outcomes when compared to kidney transplant patients with Hepatitis C and those infected with both HIV and ... read more
July 23, 2014 Treatment of HIV patients co-infected with the hepatitis C virus (HCV) with an anti-retroviral drug therapy not only tackles HIV, but also reduces HCV replication, according to a new ... read more
Jan. 15, 2014 Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new ... read more
Feb. 1, 2011 Researchers examined the role of later acquisition of hepatitis C in HIV patients in a new study. The findings suggest HIV patients should have access to ongoing screening for hepatitis ... read more